Proper management of metabolic waste is paramount for maintaining good health, and Enhance Diagnostics will enhance patient care by introducing a novel at-home breath test for ammonia. This innovative technology platform addresses the unique challenges faced by individuals with CKD and UCD, offering significant advantages in terms of convenience, cost savings, and real-time monitoring.
"The ability to monitor their disease at home is a critical problem for CKD and UCD patients. Physicians confirm that patients have been requesting more at-home monitoring capabilities. The Enhance Diagnostics device will enable them to monitor disease progression and severity from the comfort and convenience of their own homes." -Calvin Goforth, CEO.
Enhance Diagnostics enables patient monitoring in the home environment and represents a significant leap forward in addressing the challenges associated with CKD and UCD, ultimately empowering individuals to take control of their personal healthcare.
To learn more about Enhance Diagnostics, visit enhancediagnostics.com
About VIC Technology Venture Development
VIC Technology Venture Development, LLC, creates innovative companies with world-changing science and engineering-based technologies. VIC carefully selects and licenses technologies from universities and research institutions worldwide, then puts in place experienced executive management and product development teams and allocates seed capital through the global VIC Investor Network. VIC provides its portfolio companies with senior management expertise, extensive knowledge of technology startups, and proven processes to execute business strategies including legal, financial, operations, marketing, capital acquisition, and technology management. For more information, please visit victech.com